Table 4.
Mean difference in patient versus death-censored allograft survival in elderly ESP recipients versus United States recipients after 5 years of transplantation
| Patient and Graft Survival | ESP Recipients (n=1520) | United States Recipients (n=446) |
|---|---|---|
| Patient survival (yr) | 4.18±0.04 | 3.63±0.09 |
| Graft survival (yr) | 3.75±0.04 | 4.05±0.08 |
| Difference in patient and graft survival (mo) | 0.43±0.06 | −0.42±0.12 |
| 5.2±0.72 | −5.0±1.44a |
Values are mean±SEM.
a
Negative value indicates mean death-censored allograft survival exceeds mean patient survival and on average patients will die with a functioning allograft.